JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for ARDELYX, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $40,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare ESRD benefit and chronic kidney disease management

Health Issues

Issues related to medication affordability and access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.